SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-027422
Filing Date
2018-11-06
Accepted
2018-11-06 16:15:29
Documents
3
Period of Report
2018-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bold-8k_20181106.htm 8-K 35303
2 EX-99.1 bold-ex991_6.htm EX-99.1 170343
3 GRAPHIC gvuzivjiwbzx000001.jpg GRAPHIC 5248
  Complete submission text file 0001564590-18-027422.txt   214342
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 181163154
SIC: 2836 Biological Products, (No Diagnostic Substances)